1Stephens MB, Beutler AI, O' Connor FG. Museuloskeletal injections : a review of the evidence. Am Fam Physician ,2008,78 :971-976.
2Buttgereit F, da Silva JA, Boers M, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis,2002,61:718-722.
3Kirwan JR, Bijlsma JW, Boers M, et al. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev,2007, ( 1 ) :CD006356.
4Straub RH, Cutolo M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum,2007,56:399-408.
5Hoes JN, Jacobs JW, Boers M, et al. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis, 2007,66:1560- 1567.
6Recommendations for the prevention and treatment of glacocorticoid-induced ostenporosis : 2001 update. American College of Rheumatology Ad Hoc Committee on GlucocorticoidInduced Osteoporosis. Arthritis Rheum,2001,44 : 1496-1503.
7Hooper L, Brown TJ, Elliott R, et al. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review. BMJ, 2004,329:948.
8Spiegel BM, Farid M, Dulai GS, et al. Comparing rates of dyspepsia with Coxibs vs NSAID + PPI: a meta-analysis. Am J Med ,2006,119:448. e27-36.
9Bechtold S, Ripperger P, Hofner R, et al. Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study. J Pediatr,2003 ,143 :512-519.
10Grote FK, Van Suijlekom-Smit LW, Mul D, et al. Growth hormone treatment in children with rheumatic disease, corticosteroid induced growth retardation, and osteopenia. Arch Dis Child ,2006, 91:56-60.
